Safety and Effectiveness of Acarbose add on with Myoinositol on Metabolic and Hormonal Parameters in women with Polycystic Ovarian Syndrome: A Randomized Open-Label Controlled Trial

SRM College of Pharmacy SRM Institute of Science and Technology0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•a) Subjects diagnosed with PCOS based on Rotterdam criteria such as chronic anovulation- oligomenorrhea or amenorrhea, clinical or biochemical hyperandrogenism, polycystic ovarian morphology by transvaginal ultrasound.
•b) Subjects with IR ( fasting glucose: insulin ratio < 4.5)
•c) Subjects with aged 18 to 39
•d) Subjects with BMI > 25
•e) Subjects with willingness to provide informed consent will be included in the study.

•a) Subjects with diseases and conditions that mimic PCOS such as Cushing syndrome, congenital adrenal hyperplasia, idiopathic hirsutism, prolactinoma, acromegaly, type 2 DM, ovarian and adrenal androgen secreting tumours.
•b) Subjects on Oral contraceptives, glucocorticoids, antiandrogen, ovulation induction tablets, anti-diabetes, anti-obesity drugs for the past 3 months will be excluded from the study.

发起方

SRM College of Pharmacy SRM Institute of Science and Technology